6.74
price up icon4.01%   0.26
after-market After Hours: 6.74
loading
Abeona Therapeutics Inc stock is traded at $6.74, with a volume of 938.02K. It is up +4.01% in the last 24 hours and up +17.12% over the past month. Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
See More
Previous Close:
$6.48
Open:
$6.55
24h Volume:
938.02K
Relative Volume:
0.60
Market Cap:
$319.22M
Revenue:
-
Net Income/Loss:
$-54.19M
P/E Ratio:
-2.6124
EPS:
-2.58
Net Cash Flow:
$-37.34M
1W Performance:
+8.01%
1M Performance:
+17.12%
6M Performance:
+11.77%
1Y Performance:
+57.48%
1-Day Range:
Value
$6.52
$6.83
1-Week Range:
Value
$6.145
$6.83
52-Week Range:
Value
$3.9328
$7.3236

Abeona Therapeutics Inc Stock (ABEO) Company Profile

Name
Name
Abeona Therapeutics Inc
Name
Phone
646-813-4701
Name
Address
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
Name
Employee
136
Name
Twitter
@abeonabio
Name
Next Earnings Date
2024-12-11
Name
Latest SEC Filings
Name
ABEO's Discussions on Twitter

Compare ABEO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ABEO
Abeona Therapeutics Inc
6.74 319.22M 0 -54.19M -37.34M -2.58
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-02-25 Resumed Oppenheimer Outperform
Mar-05-25 Initiated Oppenheimer Outperform
Jul-03-24 Initiated H.C. Wainwright Buy
May-30-24 Initiated Stifel Buy
Nov-11-20 Upgrade Cantor Fitzgerald Neutral → Overweight
Sep-18-20 Initiated B. Riley FBR Buy
Feb-10-20 Initiated SVB Leerink Outperform
Dec-10-19 Resumed Cantor Fitzgerald Neutral
Aug-15-19 Downgrade Maxim Group Buy → Hold
Aug-12-19 Downgrade Cantor Fitzgerald Overweight → Neutral
Jul-26-19 Downgrade Mizuho Buy → Neutral
Jun-27-19 Initiated Mizuho Buy
Oct-12-18 Initiated Mizuho Buy
Jun-05-18 Initiated Seaport Global Securities Buy
Nov-08-17 Initiated SunTrust Buy
Oct-16-17 Reiterated H.C. Wainwright Buy
Oct-11-17 Reiterated Cantor Fitzgerald Overweight
Oct-10-17 Initiated Citigroup Buy
Oct-05-17 Reiterated Maxim Group Buy
Sep-15-17 Initiated RBC Capital Mkts Outperform
Jul-18-17 Reiterated Maxim Group Buy
Jun-22-17 Resumed Jefferies Buy
Jan-06-17 Initiated Jefferies Buy
Sep-29-16 Reiterated Maxim Group Buy
View All

Abeona Therapeutics Inc Stock (ABEO) Latest News

pulisher
Jun 06, 2025

ABEONA THERAPEUTICS Executives Sell Shares to Cover Tax Obligations - TradingView

Jun 06, 2025
pulisher
Jun 06, 2025

Abeona Therapeutics Officer Sells Shares to Cover Tax Obligations - TradingView

Jun 06, 2025
pulisher
Jun 05, 2025

Abeona Therapeutics: Substantially Undervalued Post-FDA Approval (Rating Upgrade) - Seeking Alpha

Jun 05, 2025
pulisher
Jun 04, 2025

Abeona Therapeutics at Jefferies Conference: ZivaSkin’s Promising Launch By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 02, 2025

Abeona Therapeutics (ABEO) Gains "Outperform" Rating from Oppenheimer | ABEO Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Abeona Therapeutics (ABEO) Gains Oppenheimer's Outperform Rating - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Abeona Therapeutics (ABEO) Grants Equity Awards to New Employees - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Abeona Therapeutics Announces New Employee Inducement Grants - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Abeona Therapeutics (ABEO) Grants Equity Awards to New Employees | ABEO Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Abeona Therapeutics® Announces New Employee Inducement Grants Un - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 02, 2025
pulisher
Jun 02, 2025

Abeona Therapeutics Awards Stock Grants Worth 11,500 Shares: New Employee Compensation Details Revealed - Stock Titan

Jun 02, 2025
pulisher
May 30, 2025

Abeona Therapeutics® to Present at the Jefferies Global Healthcare Conference - GlobeNewswire

May 30, 2025
pulisher
May 30, 2025

Abeona Therapeutics® to Present at the Jefferies Global Healthca - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Abeona Therapeutics Inc. CEO and CCO to Speak at Jefferies Global Healthcare Conference on June 4, 2025 - Nasdaq

May 30, 2025
pulisher
May 30, 2025

Abeona Therapeutics Leadership to Share Latest Company Updates at Major Healthcare Conference - Stock Titan

May 30, 2025
pulisher
May 28, 2025

Trading (ABEO) With Integrated Risk Controls - news.stocktradersdaily.com

May 28, 2025
pulisher
May 28, 2025

Director Cashes In on Abeona Therapeutics Stock! - TipRanks

May 28, 2025
pulisher
May 27, 2025

Insider Sell: Mark Alvino Sells Shares of Abeona Therapeutics In - GuruFocus

May 27, 2025
pulisher
May 27, 2025

PDD Holdings Posts Weak Results, Joins EHang Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionAbeona Therapeutics (NASDAQ:ABEO), Ascentage Pharma Group (NASDAQ:AAPG) - Benzinga

May 27, 2025
pulisher
May 27, 2025

Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket - Benzinga

May 27, 2025
pulisher
May 22, 2025

ZEVASKYN Approval Positions Abeona as Emerging Player in Dystrophic Epidermolysis Bullosa Market | DelveInsight - PR Newswire

May 22, 2025
pulisher
May 22, 2025

Dystrophic Epidermolysis Bullosa Market Predicted to See - openPR.com

May 22, 2025
pulisher
May 20, 2025

ABEO: Sells Priority Review Voucher for $155 Million… - MSN

May 20, 2025
pulisher
May 20, 2025

Abeona Therapeutics finally expanding to make cell-based gene therapy - The Business Journals

May 20, 2025
pulisher
May 19, 2025

Abeona Therapeutics Elects New Directors at Meeting - TipRanks

May 19, 2025
pulisher
May 19, 2025

ABEO: Sells Priority Review Voucher for 155 Million - Smartkarma

May 19, 2025
pulisher
May 19, 2025

Abeona targets treating 10–14 ZEVASKYN patients in 2025 while securing $155M PRV sale to extend runway - MSN

May 19, 2025
pulisher
May 18, 2025

Stifel Nicolaus Issues Pessimistic Forecast for Abeona Therapeutics (NASDAQ:ABEO) Stock Price - Defense World

May 18, 2025
pulisher
May 17, 2025

(ABEO) Trading Report - news.stocktradersdaily.com

May 17, 2025
pulisher
May 17, 2025

Abeona Therapeutics Inc. (NASDAQ:ABEO) Q1 2025 Earnings Call Transcript - Insider Monkey

May 17, 2025
pulisher
May 17, 2025

Abeona Therapeutics (NASDAQ:ABEO) Stock Rating Lowered by StockNews.com - Defense World

May 17, 2025
pulisher
May 17, 2025

Stifel cuts Abeona Therapeutics price target to $20, maintains Buy By Investing.com - Investing.com South Africa

May 17, 2025
pulisher
May 16, 2025

Abeona Therapeutics Reports Improved Financial Performance - TipRanks

May 16, 2025
pulisher
May 16, 2025

Insider Selling: Mark Alvino Sells Shares of Abeona Therapeutics Inc (ABEO) - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Abeona Therapeutics (ABEO) Transitions to Commercial Stage with ZEVASKYN Launch - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Abeona Therapeutics’ Earnings Call Highlights ZEVASKYN Success - TipRanks

May 16, 2025
pulisher
May 16, 2025

Stifel cuts Abeona Therapeutics price target to $20, maintains Buy - Investing.com Australia

May 16, 2025
pulisher
May 16, 2025

Abeona Therapeutics (ABEO): Stifel Lowers Price Target | ABEO St - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Abeona Therapeutics (ABEO): Stifel Lowers Price Target | ABEO Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Abeona Therapeutics (ABEO) Receives Revised Price Target Amid Po - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Abeona Therapeutics: Q1 Earnings Snapshot - CT Insider

May 16, 2025
pulisher
May 15, 2025

Earnings call transcript: Abeona Therapeutics beats EPS forecast in Q1 2025 - Investing.com Nigeria

May 15, 2025
pulisher
May 15, 2025

Abeona Therapeutics (ABEO) Target Price Raised Following FDA Approval and Strategic Sale | ABEO Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Abeona Therapeutics (ABEO) Exceeds EPS Estimates, Bolstered by S - GuruFocus

May 15, 2025
pulisher
May 15, 2025

ABEO Shows Decrease in Cash Reserves Before PRV Sale Completion - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Abeona Therapeutics (ABEO) Launches ZEVASKYN, A Milestone in Gen - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Abeona Therapeutics® Reports First Quarter 2025 Financial Results and Corporate Updates | ABEO Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

ABEO Shows Decrease in Cash Reserves Before PRV Sale Completion | ABEO Stock News - GuruFocus

May 15, 2025

Abeona Therapeutics Inc Stock (ABEO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
Cap:     |  Volume (24h):